HUTCHMED (China) Limited Logo

HUTCHMED (China) Limited (H7T2)

FSX

Currency in EUR
2.08
+0.06 (+2.97%)

Real-time Data

06:00 AM

Day's Range

2.08
2.08

52 wk Range

1.65
3.00

Overview - H7T2 - HUTCHMED (China) Limited

Key Statistics

Valuation

Enterprise Value

380.48M

P/E (Trailing)

‪98.50‬

Price / Sales (TTM)

‪3.11‬

Price / Book

‪1.57‬

EV / EBITDA

‪-21.65‬

Profitability

Gross Margin

‪23.08%‬

Profit Margin

‪3.25%‬

Operating Margin

‪0.31%‬

Return on Assets

‪-1.23%‬

Return on Equity

‪1.46%‬

Ownership

Shares Outstanding

859.74M

Float

522.93M

Held by Insiders

‪38.79%‬

Held by Institutions

‪19.43%‬

Price stats

Beta

‪0.43‬

50-Day Avg

‪1.86‬

200-Day Avg

‪2.15‬

Dividends

Payout Ratio

‪0.00%‬

Peers - H7T2 - HUTCHMED (China) Limited

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.

Profile Summary - H7T2 - HUTCHMED (China) Limited

About

HUTCHMED (China) Limited is an innovative, commercial-stage biopharmaceutical company headquartered in Hong Kong, focused on the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases. Established over two decades ago as one of China's first…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1.78K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.